TRAITEMENT DU CANCER DU SEIN AU MOYEN D'UNE ASSOCIATION D'UNE FORMULATION DE TAXANE LIPOSOMALE CATIONIQUE, D'UNE FORMULATION DE TAXANE NON LIPOSOMALE ET D'UN AUTRE PRINCIPE ACTIF

• 收藏
• 分享

专利权人:

SYNCORE BIOTECHNOLOGY CO.; LTD;SYNCORE BIOTECHNOLOGY CO., LTD;CANCAP PHARMACEUTICAL LTD.

发明人:

LIN, SIH-TING,TSENG, HUI-YUAN,TENG, HSIN-WEI

申请号：

CA3009608

公开号：

CA3009608A1

申请日:

2016.12.28

申请国别(地区):

CA

年份:

2017

代理人:

摘要：

The present disclosure provides methods for the treatment of breast cancer, including triple negative breast cancer. Said methods comprise the administration of (a) a cationic liposomal formulation comprising a taxane, (b) a non-liposomal formulations comprising a taxane and (c) a further active agent. Said further active agent is preferably gemcitabine.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/